ctrl K

Watchlist Price Alert

Entrada Therapeutics Inc. (TRDA)

NASDAQ: TRDA · Real-Time Price · USD

7.50

0.09 (1.21%)

At close: Jun 17, 2025, 10:54 AM

Entrada Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	101.21M	67.6M	45.16M	291.06M	39.05M	16.84M
Short-Term Investments	318.79M	284.37M	143.56M	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	3.95M	n/a	n/a	n/a
Other Long-Term Assets	4.23M	6.74M	5.21M	872K	541K	-801K
Receivables	3.68M	5.88M	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	16.36M	11.92M	21.16M	n/a	n/a	n/a
Total Current Assets	440.04M	369.77M	209.88M	298.7M	39.95M	17.44M
Property-Plant & Equipment	82.05M	92.68M	33.02M	6.26M	3.04M	801K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	86.28M	99.42M	42.18M	7.13M	3.58M	801K
Total Assets	526.32M	469.19M	252.06M	305.83M	43.53M	18.24M
Account Payables	4.26M	3.28M	5.99M	706K	1.6M	710K
Deferred Revenue	13.65M	132.26M	n/a	n/a	n/a	n/a
Short-Term Debt	7.56M	7.02M	8.41M	n/a	n/a	n/a
Other Current Liabilities	5.95M	11.69M	-2.91M	485K	115K	219K
Total Current Liabilities	39.48M	158.8M	21.97M	6.72M	3.36M	1.92M
Long-Term Debt	51.65M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	396K	n/a	31.84M
Total Long-Term Liabilities	58.16M	68.04M	17.53M	396K	81.66M	31.84M
Total Liabilities	97.64M	226.83M	39.5M	7.12M	85.02M	33.76M
Total Debt	59.21M	68.23M	25.94M	n/a	n/a	n/a
Common Stock	4K	3K	3K	3K	1K	1K
Retained Earnings	-129.34M	-194.97M	-188.28M	-93.67M	-42.51M	-15.99M
Comprehensive Income	-43K	195K	-2.06M	-305.83M	-81.66M	-31.82M
Shareholders Equity	428.68M	242.36M	212.55M	298.72M	-41.49M	-15.52M
Total Investments	318.79M	284.37M	143.56M	n/a	n/a	n/a